Background: The treatment of patients with breast cancer has undergone many
revisions over recent decades. The current trend is toward limited resecti
ons and breast conservation. Some authors advocate the abandonment of axill
ary lymph node dissection (ALND) for small tumors. While it is accepted tha
t ALND has no therapeutic effect in breast cancer patients, its prognostic
significance for small tumors is debated. Eligibility criteria for surgical
treatment without axillary dissection are evolving.
Methods: Considering that problem, we retrospectively reviewed the charts o
f 100 patients with T1 invasive carcinoma of the breast treated at Hippokra
tion Hospital of Athens between 1986 and 1987. Patients were divided into t
wo groups: those that underwent ALND (n=76) and those that did not (n=24).
The following data were recorded: age, tumor size, grade, hormone receptor
status and postoperative treatment. The ten-year overall and disease-free s
urvival were analysed. A multivariate analysis was used to identify prognos
tic variables.
Results: There was no statistically significant difference in the ten-year
overall and disease-free survival between the two groups. The univariate an
alysis showed that tumor size predicts both recurrence and survival. In the
multivariate analysis tumor size was found to be an independent prognostic
factor for overall survival.
Conclusions: ALND did not influence the ten-year survival or the recurrence
rate. Tumor size was the only statistically significant and independent pr
ognostic factor for T1 breast cancer patients.